BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22677619)

  • 21. URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Zhang L; Huang H; Zhang L; Hou T; Wu S; Huang Q; Song L; Liu J
    BMC Cancer; 2014 Nov; 14():885. PubMed ID: 25427922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.
    Huang J; Zhu B; Lu L; Lian Z; Wang Y; Yang X; Satiroglu-Tufan NL; Liu J; Luo Z
    Pathology; 2009 Feb; 41(2):149-54. PubMed ID: 18972316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
    Baghdassarian N; Bertrand Y; Ffrench P; Duhaut P; Bryon PA; Ffrench M
    Br J Haematol; 2000 Apr; 109(1):109-16. PubMed ID: 10848789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance.
    Malak CA; Elghanam DM; Elbossaty WF
    Asian Pac J Cancer Prev; 2015; 16(18):8197-201. PubMed ID: 26745060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro drug sensitivity and expression profiling for disease prognostication in childhood acute lymphoblastic leukaemia (ALL): an exploratory model using cell lines.
    Liu XG; Chen SP; Kham SK; Quah TC; Yeoh AE
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S21-2. PubMed ID: 15651190
    [No Abstract]   [Full Text] [Related]  

  • 31. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.
    Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
    Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.
    Qiu J; Gunaratne P; Peterson LE; Khurana D; Walsham N; Loulseged H; Karni RJ; Roussel E; Gibbs RA; Margolin JF; Gingras MC
    Leukemia; 2003 Sep; 17(9):1891-900. PubMed ID: 12970791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of p300 gene promoter methylation in acute leukemia.
    Chim CS; Wong AS; Kwong YL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
    Lambrou GI; Vlahopoulos S; Papathanasiou C; Papanikolaou M; Karpusas M; Zoumakis E; Tzortzatou-Stathopoulou F
    Leuk Res; 2009 Dec; 33(12):1684-95. PubMed ID: 19450877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute lymphoblastic leukemia associated with a t(1;19)(q23;p13) in an adult.
    Ohno H; Inoue T; Akasaka T; Okumura A; Miyanishi S; Ohashi I; Kikuchi M; Masuya M; Amano H; Imanaka T
    Intern Med; 1993 Jul; 32(7):584-7. PubMed ID: 8286840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
    Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling in childhood acute leukemia: progress and perspectives.
    Hayashi Y
    Int J Hematol; 2003 Dec; 78(5):414-20. PubMed ID: 14704033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.